GLAUCOMA Research Foundation Appoints Julie S. Austin, MNO, Vice President of Philanthropy
SAN FRANCISCO, July 30, 2026 /PRNewswire/ -- Glaucoma Research Foundation (GRF) today announced the appointment of Julie S. Austin, MNO,...
Read moreDetails
Press Releases – Lifestyle
Natura revenue under pressure in Brazil, while Hispanic markets deliver growth and higher profitability in 2Q26
Revenue of BRL 5.2 billion reflects pressure in Brazil caused by operational challenges, temporary tax effects, and the macroeconomic environmentHispanic...
Read moreDetailsNNB and Axiom Foods Deliver Next-Generation Protein Solutions to Address Growing Global Whey Supply Challenges
As protein expands into every category of food and beverage, NNB introduces a scalable platform of advanced plant proteins and...
Read moreDetailsSILVERCORP REPORTS ADJUSTED NET INCOME OF $53.9 MILLION, $0.24 PER SHARE, AND CASH FLOW FROM OPERATING ACTIVITIES OF $61.7 MILLION FOR Q1 FISCAL 2027
Trading Symbol: TSX/NYSE AMERICAN: SVMVANCOUVER, BC, Aug. 10, 2026 /PRNewswire/ -- Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM)...
Read moreDetailsSouthwest Airlines Appoints Jason Liberty and Varun Krishna to Board of Directors
DALLAS, Aug. 10, 2026 /PRNewswire/ -- Southwest Airlines Co. (NYSE: LUV) today announced Jason Liberty, Chairman and Chief Executive Officer, Royal Caribbean Group, and...
Read moreDetailsFALCON GOLD CORP. RESTATES NON-BROKERED PRIVATE PLACEMENT
FG: TSX-VVANCOUVER, BC, Aug. 10, 2026 /PRNewswire/ -- Falcon Gold Corp. (TSXV: FG) (FSE: 3FA) (OTC Pink: FGLDF) ("Falcon" or...
Read moreDetails
Mercy Medical Center’s Institute for Foot and Ankle Reconstruction Opens Center for Orthopedic Innovation, Advancing Research, Education and Surgical Innovation
Seven-Year Vision Led by Orthopedic Innovator Dr. Lew Schon Expands Mercy's Leadership in Foot and Ankle Care featuring cutting-edge orthobiologic...
Read moreDetailsi-80 Gold Reports Second Quarter 2026 Results; On Track to Achieve Full-Year Guidance as Granite Creek Ramps Up and Development Plan Advances
TORONTO, Aug. 10, 2026 /PRNewswire/ -- i-80 GOLD CORP. (NYSE:IAUX) (TSX:IAU) ("i-80 Gold" or the "Company") reports its financial and operating...
Read moreDetails
Emergent BioSolutions Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Emergent BioSolutions (EBS)
Emergent BioSolutions cut FY2026 revenue guidance to $645-$675 million after reaffirming a $720-$760 million outlook three months earlier. Levi &...
Read moreDetails
Exelixis Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Exelixis (EXEL)
On May 5, 2026, Exelixis management reiterated full-year 2026 financial guidance. Weeks later, the Company lowered and narrowed that revenue...
Read moreDetails